Education
About Us
Working with TipRanks
Follow Us
Addex Therapeutics Ltd (ADR) (ADXN)
:ADXN
ADXN Stock Chart & Stats
$10.95
$0.23(2.80%)
At close: 4:00 PM EST
$10.95
$0.23(2.80%)
Day’s Range― - ―
52-Week Range$6.51 - $12.05
Previous CloseN/A
Volume26.36K
Average Volume (3M)17.48K
Market Cap
$10.88M
Enterprise Value$5.04M
Total Cash (Recent Filing)$2.30M
Total Debt (Recent Filing)$38.39K
Price to Earnings (P/E)―
Beta0.30
Next Earnings
Nov 10, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.02
Shares Outstanding1,822,121
10 Day Avg. Volume4,385
30 Day Avg. Volume17,479
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.54
Price to Sales (P/S)12.67
P/FCF Ratio-0.97
Enterprise Value/Market Cap0.46
Enterprise Value/Revenue30.96
Enterprise Value/Gross Profit751.26
Enterprise Value/Ebitda-1.04
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)-10.46
Revenue Forecast (FY)$1.79M
Addex Therapeutics News
ADXN FAQ
What was Addex Therapeutics Ltd (ADR)’s price range in the past 12 months?
Addex Therapeutics Ltd (ADR) lowest stock price was $6.51 and its highest was $12.05 in the past 12 months.
What is Addex Therapeutics Ltd (ADR)’s market cap?
Addex Therapeutics Ltd (ADR)’s market cap is $10.88M.
When is Addex Therapeutics Ltd (ADR)’s upcoming earnings report date?
Addex Therapeutics Ltd (ADR)’s upcoming earnings report date is Nov 10, 2025 which is yesterday.
How were Addex Therapeutics Ltd (ADR)’s earnings last quarter?
Addex Therapeutics Ltd (ADR) released its earnings results on Sep 30, 2025. The company reported -$3.016 earnings per share for the quarter, missing the consensus estimate of N/A by -$3.016.
Is Addex Therapeutics Ltd (ADR) overvalued?
According to Wall Street analysts Addex Therapeutics Ltd (ADR)’s price is currently Overvalued.
Does Addex Therapeutics Ltd (ADR) pay dividends?
Addex Therapeutics Ltd (ADR) does not currently pay dividends.
What is Addex Therapeutics Ltd (ADR)’s EPS estimate?
Addex Therapeutics Ltd (ADR)’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Addex Therapeutics Ltd (ADR) have?
Addex Therapeutics Ltd (ADR) has 1,822,121 shares outstanding.
What happened to Addex Therapeutics Ltd (ADR)’s price movement after its last earnings report?
Addex Therapeutics Ltd (ADR) reported an EPS of -$3.016 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 5.111%.
Which hedge fund is a major shareholder of Addex Therapeutics Ltd (ADR)?
Currently, no hedge funds are holding shares in ADXN
Company Description
Addex Therapeutics Ltd (ADR)
Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing innovative treatments for central nervous system (CNS) disorders. The company specializes in allosteric modulation, which involves the development of compounds targeting metabotropic glutamate receptors (mGluRs) to address various neurological and psychiatric conditions. Addex's pipeline includes candidates for treating indications such as Parkinson's disease, schizophrenia, and anxiety disorders, aiming to improve patient outcomes through novel mechanisms of action.
ADXN Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a balanced view with significant achievements in collaborative and strategic partnerships, financial stability, and progress in R&D. However, there were challenges related to decreased income, increased net loss from an associated venture, and limited cash for unpartnered programs.View all ADXN earnings summariesTechnical Analysis
Kiora Pharmaceuticals
―
Xenetic Biosciences
―
Nucana
―
Creative Medical Technology Holdings
―
HCW Biologics
―
Ownership Overview
―
Insiders
―
Mutual Funds
0.07% Other Institutional Investors
99.93% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---